+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Molluscum Contagiosum - Epidemiology Forecast - 2028

  • ID: 4871921
  • Report
  • December 2019
  • Region: Global
  • 63 pages
  • DelveInsight
1 of 2
‘Molluscum Contagiosum - Epidemiology Forecast - 2028' report deliver an in - depth understanding of the disease, historical & forecasted epidemiology trends of Molluscum Contagiosum in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan.

Geography Covered
  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan
Study Period: 2017 - 2028

Molluscum Contagiosum - Disease Understanding

Molluscum Contagiosum (MC) is a common superficial skin infection caused by the poxvirus. It is characterized by painless white or skin - colored papular skin - lesions that are generally 2 - 5 mm in size, though early lesions can be smaller. The patients typically have 1 - 20 molluscum lesions, although even healthy patients may have a hundred or more lesions.

The virus is transmitted mainly by direct contact with infected skin, which can be sexual, nonsexual, or autoinoculation. It is common in children and generally presents with asymptomatic lesions; however, it can present with pruritus, erythema, and on some occasions, bacterial super infections with inflammation and pain. In normal hosts, MC is benign natured, limited to the skin, but lesions can take as long as 6 - 12 months to resolve. Immunocompromised patients can develop very large (>15 mm) and numerous lesions, and bacterial super infections

Molluscum Contagiosum - Epidemiology

The Molluscum Contagiosum epidemiology division provide insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Prevalence of Molluscum Contagiosum in 7MM, Gender - Specific Prevalence of Molluscum Contagiosum in 7MM, Age - Specific Prevalence of Molluscum Contagiosum), scenario of Molluscum Contagiosum in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017 - 2028.

This estimations suggests the total prevalent cases of Molluscum Contagiosum in the 7MM was found to be approximately 12,161,039 in 2017. Among 7MM, United States has the prevalent population of Molluscum Contagiosum with about 6,163,809 cases in 2017. In 2017 among EU - 5 countries, UK has the highest prevalent cases with 1,066,107, followed by Germany with 950,724 cases. While, Spain has the least number of prevalent cases with approximately 678,589.

In 2017, the prevalent population of Molluscum Contagiosum in Japan was found to be approximately 1,584,927.

The MC predominately effects the children under the age of 15, however, recently, it has been observed that Adults with HIV infection or immunocompromised patients are also added to the prevalent pool, which is now making MC as Children and Adult - specific disease. Among the Children - specific cases, US has the highest number of patients with 6,113,396 in 2017 and Adult - specific cases are reported around 50,413.

Molluscum Contagiosum Report Insights
  • The report covers a descriptive overview of the Molluscum Contagiosum, explaining its causes, risk factors, pathophysiology and diagnosis.
  • Comprehensive insight has been provided into the epidemiology Molluscum Contagiosum in the 7MM countries covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • Assesses growth opportunities in the 7MM countries with respect to the patient population.
Molluscum Contagiosum Report Key Strengths
  • 10 Year Forecast
  • 7MM Coverage
  • Total Patient Pool with Molluscum Contagiosum
  • Age - Specific Diagnosed Patient Pool of Molluscum Contagiosum
  • Gender - Specific Diagnosed Patient Pool of Molluscum Contagiosum
Molluscum Contagiosum Report Assessment
  • Current Treatment Practices
  • Unmet Needs
  • Detailed Pipeline Product Profiles
Key Benefits
  • Key assessments
  • Patient Segmentation
  • Disease Risk & Burden
Note: Product cover images may vary from those shown
2 of 2

1. Key Insights

2. Molluscum Contagiosum: Patient Overview at a Glance
2.1. Patient Share (%) Distribution of Molluscum Contagiosum in 2017
2.2. Patient Share (%) Distribution of Molluscum Contagiosum in 2028

3. Disease Overview: Molluscum Contagiosum
3.1. Introduction
3.2. Classification
3.3. Clinical features
3.4. Genetics
3.5. Pathophysiology
3.6. Diagnosis

4. Epidemiology and Patient Population
4.1. Key Findings
4.2. 7MM Total Prevalent Patient Population of Molluscum Contagiosum
4.3. Country Wise-Epidemiology of Molluscum Contagiosum
4.4. United States
4.4.1. Assumptions and Rationale
4.4.2. Prevalent Cases of Molluscum Contagiosum in the United States
4.4.3. Gender-Specific Cases of Molluscum Contagiosum in the United States
4.4.4. Age-Specific Cases of Molluscum Contagiosum in the United States
4.4.5. Diagnosed Cases of Molluscum Contagiosum in the United States
4.4.6. Type-Specific Cases of Molluscum Contagiosum in the United States
4.5. EU5
4.5.1. Assumptions and Rationale
4.6. Germany
4.6.1. Prevalent Cases of Molluscum Contagiosum in Germany
4.6.2. Gender-Specific Cases of Molluscum Contagiosum in Germany
4.6.3. Age-Specific Cases of Molluscum Contagiosum in Germany
4.6.4. Diagnosed Cases of Molluscum Contagiosum in Germany
4.6.5. Type-Specific Diagnosed Cases of Molluscum Contagiosum in Germany
4.7. France
4.7.1. Prevalent Cases of Molluscum Contagiosum in France
4.7.2. Gender-Specific Cases of Molluscum Contagiosum in France
4.7.3. Age-Specific Cases of Molluscum Contagiosum in France
4.7.4. Diagnosed Cases of Molluscum Contagiosum in France
4.7.5. Type-Specific Cases of Molluscum Contagiosum in France
4.8. Italy
4.8.1. Prevalent Cases of Molluscum Contagiosum in Italy
4.8.2. Gender-Specific Cases of Molluscum Contagiosum in Italy
4.8.3. Age-Specific Cases of Molluscum Contagiosum in Italy
4.8.4. Diagnosed Cases of Molluscum Contagiosum in Italy
4.8.5. Type-Specific Cases of Molluscum Contagiosum in Italy
4.9. Spain
4.9.1. Prevalent Cases of Molluscum Contagiosum in Spain
4.9.2. Gender-Specific Cases of Molluscum Contagiosum in Spain
4.9.3. Age-Specific Cases of Molluscum Contagiosum in Spain
4.9.4. Diagnosed Cases of Molluscum Contagiosum in Spain
4.9.5. Type-Specific Cases of Molluscum Contagiosum in Spain
4.10. United Kingdom
4.10.1. Prevalent Cases of Molluscum Contagiosum in United Kingdom
4.10.2. Gender-Specific Cases of Molluscum Contagiosum in the United Kingdom
4.10.3. Age-Specific Cases of Molluscum Contagiosum in the United Kingdom
4.10.4. Diagnosed Cases of Molluscum Contagiosum in the United Kingdom
4.10.5. Type-Specific Diagnosed Cases of Molluscum Contagiosum in the United Kingdom
4.11. Japan
4.11.1. Assumptions and Rationale
4.11.2. Prevalent Cases of Molluscum Contagiosum in Japan
4.11.3. Gender-Specific Cases of Molluscum Contagiosum in Japan
4.11.4. Age-Specific Cases of Molluscum Contagiosum in Japan
4.11.5. Diagnosed Cases of Molluscum Contagiosum in Japan
4.11.6. Type-Specific Diagnosed Cases of Molluscum Contagiosum in Japan

5. Appendix
5.1. Report Methodology

6. Publisher Capabilities

7. Disclaimer

8. About the Publisher

Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll